| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.982 | 0.001 | 0.982 | 5-Lipoxygenase inhibitor | 0.898 0.002 DBMET00138 0.862 0.002 DBMET00139 0.279 0.012 DBMET00140 0.396 0.005 DBMET00141 0.25 0.016 DBMET01255 | ||
| 0.949 | 0.003 | 0.949 | Lipoxygenase inhibitor | 0.776 0.004 DBMET00138 0.576 0.011 DBMET00139 0.32 0.062 DBMET00140 0.491 0.02 DBMET01255 | ||
| 0.846 | 0.01 | 0.846 | Antiinflammatory | 0.752 0.022 DBMET00138 0.79 0.017 DBMET00139 0.738 0.024 DBMET00141 | ||
| 0.826 | 0.005 | 0.826 | Toll-Like receptor 7 agonist | 0.367 0.074 DBMET00138 0.377 0.069 DBMET00139 | ||
| 0.822 | 0.005 | 0.822 | Toll-Like receptor agonist | 0.355 0.079 DBMET00138 0.366 0.074 DBMET00139 | ||
| 0.782 | 0.002 | 0.782 | Leukotriene synthesis inhibitor | 0.472 0.003 DBMET00138 0.657 0.002 DBMET00139 0.083 0.035 DBMET00141 0.389 0.003 DBMET01255 | ||
| 0.423 | 0.065 | 0.423 | 15-Lipoxygenase inhibitor | 0.343 0.104 DBMET00138 | ||
| 0.281 | 0.02 | 0.281 | Cyclooxygenase inhibitor | 0.177 0.052 DBMET00138 0.146 0.074 DBMET00139 | ||
| 0.25 | 0.004 | 0.25 | NMDA receptor agonist | 0.085 0.026 DBMET00138 0.102 0.019 DBMET00140 0.096 0.021 DBMET01255 | ||
| 0.288 | 0.058 | 0.395 | Tumour necrosis factor alpha release inhibitor | 0.36 0.035 DBMET00139 0.395 0.028 DBMET01255 | DBMET01255 | |
| 0.261 | 0.055 | 0.261 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.247 0.062 DBMET00140 0.198 0.092 DBMET01255 | ||
| 0.2 | 0.003 | 0.2 | NMDA receptor glycine site agonist | 0.099 0.017 DBMET00138 0.063 0.043 DBMET00139 0.112 0.011 DBMET00140 0.096 0.019 DBMET01255 | ||
| 0.198 | 0.004 | 0.198 | Leukotriene A4 hydrolase inhibitor | 0.051 0.02 DBMET00138 0.035 0.028 DBMET00139 | ||
| 0.228 | 0.093 | 0.245 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 DBMET00138 0.202 0.131 DBMET00139 0.215 0.111 DBMET00140 0.23 0.09 DBMET01255 | DBMET00138 | |
| 0.169 | 0.069 | 0.169 | Peroxidase inhibitor | 0.118 0.102 DBMET00138 0.143 0.082 DBMET01255 | ||
| 0.176 | 0.076 | 0.176 | LIM domain kinase 1 inhibitor | |||
| 0.13 | 0.047 | 0.13 | Aminopeptidase B inhibitor | 0.085 0.077 DBMET00138 0.094 0.069 DBMET00139 0.088 0.074 DBMET00140 0.098 0.066 DBMET01255 | ||
| 0.133 | 0.051 | 0.202 | DNA repair enzyme inhibitor | 0.115 0.083 DBMET00138 0.122 0.068 DBMET00140 0.202 0.009 DBMET00141 | DBMET00141 | |
| 0.149 | 0.067 | 0.254 | Cell wall synthesis inhibitor | 0.138 0.077 DBMET00138 0.118 0.102 DBMET00139 0.163 0.054 DBMET00140 0.254 0.015 DBMET00141 0.173 0.045 DBMET01255 | DBMET00141 | |
| 0.147 | 0.068 | 0.171 | Adenylate cyclase stimulant | 0.142 0.078 DBMET00138 0.171 0.034 DBMET00140 0.122 0.12 DBMET00141 0.132 0.098 DBMET01255 | DBMET00140 | |
| 0.237 | 0.163 | 0.284 | Calcium channel activator | 0.253 0.143 DBMET00138 0.284 0.109 DBMET00140 0.249 0.148 DBMET01255 | DBMET00140 | |
| 0.103 | 0.03 | 0.107 | Vanilloid agonist | 0.107 0.026 DBMET00138 0.079 0.074 DBMET00139 0.088 0.052 DBMET00140 | DBMET00138 | |
| 0.071 | 0.008 | 0.121 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.121 0.005 DBMET00138 0.107 0.005 DBMET00140 | DBMET00138 | |
| 0.072 | 0.01 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 DBMET00140 0.056 0.035 DBMET01255 | ||
| 0.153 | 0.096 | 0.19 | 3C-like protease (Human coronavirus) inhibitor | 0.19 0.058 DBMET00140 0.141 0.117 DBMET01255 | DBMET00140 | |
| 0.095 | 0.038 | 0.095 | CYP2A6 inhibitor | 0.082 0.046 DBMET00140 | ||
| 0.083 | 0.028 | 0.083 | Histone deacetylase inhibitor | 0.071 0.039 DBMET00140 | ||
| 0.203 | 0.149 | 0.208 | 12-Lipoxygenase inhibitor | 0.208 0.143 DBMET00138 | DBMET00138 | |
| 0.086 | 0.034 | 0.329 | Selectin antagonist | 0.091 0.031 DBMET00138 0.226 0.009 DBMET00139 0.107 0.025 DBMET00140 0.329 0.004 DBMET00141 0.236 0.009 DBMET01255 | DBMET00141 | |
| 0.056 | 0.006 | 0.131 | VCAM-1 antagonist | 0.048 0.011 DBMET00138 0.131 0.004 DBMET00140 0.038 0.034 DBMET00141 0.053 0.008 DBMET01255 | DBMET00140 | |
| 0.056 | 0.006 | 0.132 | VCAM antagonist | 0.047 0.011 DBMET00138 0.132 0.004 DBMET00140 0.038 0.034 DBMET00141 0.052 0.008 DBMET01255 | DBMET00140 | |
| 0.136 | 0.087 | 0.158 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.158 0.067 DBMET00138 0.145 0.079 DBMET00140 | DBMET00138 | |
| 0.078 | 0.033 | 0.078 | Neutrophil collagenase inhibitor | |||
| 0.063 | 0.022 | 0.089 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.043 DBMET00138 0.089 0.01 DBMET00140 | DBMET00140 | |
| 0.059 | 0.019 | 0.059 | Macrophage elastase inhibitor | 0.038 0.036 DBMET00138 0.049 0.025 DBMET00139 | ||
| 0.072 | 0.035 | 0.072 | Glutamate (mGluR6) antagonist | 0.068 0.044 DBMET00140 0.062 0.06 DBMET01255 | ||
| 0.044 | 0.009 | 0.044 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 DBMET00138 | ||
| 0.049 | 0.017 | 0.049 | Histone deacetylase 5 inhibitor | |||
| 0.048 | 0.017 | 0.099 | TRPM8 blocker | 0.099 0.007 DBMET00140 | DBMET00140 | |
| 0.06 | 0.029 | 0.06 | Leukotriene C antagonist | |||
| 0.115 | 0.085 | 0.115 | Cyclooxygenase 1 inhibitor | |||
| 0.194 | 0.164 | 0.236 | 5 Hydroxytryptamine uptake stimulant | 0.218 0.12 DBMET00140 0.236 0.096 DBMET01255 | DBMET01255 | |
| 0.076 | 0.048 | 0.111 | Vanilloid 4 agonist | 0.111 0.01 DBMET00140 0.076 0.048 DBMET01255 | DBMET00140 | |
| 0.041 | 0.013 | 0.041 | Histone deacetylase class II inhibitor | 0.026 0.023 DBMET00138 0.026 0.023 DBMET00139 | ||
| 0.076 | 0.048 | 0.076 | Glutamate decarboxylase inhibitor | 0.074 0.05 DBMET00138 | ||
| 0.04 | 0.014 | 0.04 | Peptide deformylase inhibitor | |||
| 0.038 | 0.013 | 0.038 | Histone deacetylase 1 inhibitor | |||
| 0.117 | 0.093 | 0.134 | Cytokine production inhibitor | 0.134 0.076 DBMET01255 | DBMET01255 | |
| 0.037 | 0.013 | 0.037 | Histone deacetylase class IIb inhibitor | 0.023 0.021 DBMET00138 0.024 0.02 DBMET00139 0.024 0.019 DBMET00140 | ||
| 0.037 | 0.013 | 0.037 | Histone deacetylase 6 inhibitor | 0.023 0.02 DBMET00138 0.023 0.02 DBMET00139 0.024 0.019 DBMET00140 | ||
| 0.138 | 0.115 | 0.138 | Tumour necrosis factor antagonist | |||
| 0.143 | 0.121 | 0.143 | Phospholipase C inhibitor | |||
| 0.038 | 0.018 | 0.038 | Histone deacetylase class IIa inhibitor | |||
| 0.028 | 0.012 | 0.028 | Complement factor 1s inhibitor | 0.026 0.015 DBMET00140 0.025 0.019 DBMET01255 | ||
| 0.059 | 0.043 | 0.059 | Collagenase 3 inhibitor | |||
| 0.039 | 0.026 | 0.039 | Leukotriene C4 antagonist | |||
| 0.034 | 0.021 | 0.034 | Histone deacetylase 4 inhibitor | |||
| 0.093 | 0.081 | 0.109 | Adenylate kinase inhibitor | 0.109 0.055 DBMET01255 | DBMET01255 | |
| 0.034 | 0.023 | 0.034 | Histone deacetylase 2 inhibitor | |||
| 0.049 | 0.038 | 0.13 | Factor IXa inhibitor | 0.101 0.009 DBMET00138 0.114 0.007 DBMET00140 0.13 0.005 DBMET00141 | DBMET00141 | |
| 0.062 | 0.052 | 0.107 | Sphingosine 1-phosphate receptor 4 agonist | 0.107 0.022 DBMET00140 | DBMET00140 | |
| 0.051 | 0.042 | 0.054 | Leukotriene B4 antagonist | 0.054 0.037 DBMET00138 | DBMET00138 | |
| 0.052 | 0.044 | 0.052 | Thromboxane synthase inhibitor | |||
| 0.032 | 0.026 | 0.032 | ADAM10 endopeptidase inhibitor | |||
| 0.039 | 0.033 | 0.042 | Neurokinin 2 agonist | 0.042 0.027 DBMET00140 | DBMET00140 | |
| 0.019 | 0.013 | 0.036 | Factor IX inhibitor | 0.022 0.01 DBMET00138 0.036 0.005 DBMET00140 | DBMET00140 | |
| 0.038 | 0.034 | 0.101 | Acetyl-CoA carboxylase inhibitor | 0.079 0.008 DBMET00140 0.101 0.005 DBMET01255 | DBMET01255 | |
| 0.034 | 0.04 | 0.038 | Aggrecanase 1 inhibitor | 0.038 0.03 DBMET00139 | DBMET00139 | |
| 0.009 | 0.018 | 0.016 | Human herpes virus 5 capsid protein P40 inhibitor | 0.016 0.005 DBMET00139 0.015 0.006 DBMET01255 | DBMET00139 | |
| 0.014 | 0.025 | 0.017 | Complement factor 1 inhibitor | 0.017 0.013 DBMET00140 | DBMET00140 | |
| 0.048 | 0.059 | 0.083 | Carbamoyl phosphate synthetase inhibitor | 0.083 0.027 DBMET01255 | DBMET01255 | |
| 0.053 | 0.064 | 0.08 | I kappa B kinase 2 inhibitor | 0.08 0.023 DBMET01255 | DBMET01255 | |
| 0.013 | 0.03 | 0.064 | Acetyl-CoA carboxylase 2 inhibitor | 0.042 0.009 DBMET00140 0.064 0.005 DBMET01255 | DBMET01255 | |
| 0.13 | 0.15 | 0.15 | Non-steroidal antiinflammatory agent | 0.15 0.115 DBMET00141 | DBMET00141 | |
| 0.029 | 0.05 | 0.036 | Dopamine D5 agonist | 0.036 0.034 DBMET00138 0.036 0.033 DBMET00140 | DBMET00140 | |
| 0.106 | 0.128 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.118 0.087 DBMET00138 0.124 0.072 DBMET00140 0.127 0.066 DBMET01255 | DBMET01255 | |
| 0.011 | 0.035 | 0.041 | Acetyl-CoA carboxylase 1 inhibitor | 0.041 0.007 DBMET01255 | DBMET01255 | |
| 0.061 | 0.087 | 0.077 | Keratolytic | 0.069 0.068 DBMET00138 0.077 0.053 DBMET00140 | DBMET00140 | |
| 0.062 | 0.096 | 0.095 | I kappa B kinase inhibitor | 0.095 0.043 DBMET01255 | DBMET01255 | |
| 0.076 | 0.119 | 0.091 | Alpha 2d adrenoreceptor antagonist | 0.091 0.068 DBMET00140 | DBMET00140 | |
| 0.036 | 0.08 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.047 DBMET00138 | DBMET00138 | |
| 0.156 | 0.201 | 0.186 | Transcription factor STAT3 inhibitor | 0.186 0.154 DBMET01255 | DBMET01255 | |
| 0.142 | 0.187 | 0.244 | DNA damaging | 0.244 0.084 DBMET01255 | DBMET01255 | |
| 0.065 | 0.114 | 0.09 | Triose-phosphate isomerase inhibitor | 0.09 0.06 DBMET00141 | DBMET00141 | |
| 0.051 | 0.11 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.06 DBMET00140 | DBMET00140 | |
| 0.049 | 0.109 | 0.075 | Glutamate dehydrogenase inhibitor | 0.075 0.05 DBMET01255 | DBMET01255 | |
| 0.044 | 0.106 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 DBMET01255 | DBMET01255 | |
| 0.018 | 0.084 | 0.088 | Urokinase inhibitor | 0.043 0.037 DBMET00138 0.088 0.019 DBMET00140 | DBMET00140 | |
| 0.023 | 0.092 | 0.061 | Antibiotic Aminoglycoside-like | 0.061 0.008 DBMET00141 | DBMET00141 | |
| 0.104 | 0.179 | 0.169 | Sphingosine 1-phosphate receptor 5 antagonist | 0.132 0.095 DBMET00140 0.169 0.035 DBMET01255 | DBMET01255 | |
| 0.068 | 0.149 | 0.114 | Mucolytic | 0.114 0.06 DBMET00140 0.102 0.075 DBMET00141 0.099 0.079 DBMET01255 | DBMET00140 | |
| 0.037 | 0.121 | 0.057 | DNA helicase inhibitor | 0.057 0.033 DBMET00140 | DBMET00140 | |
| 0.03 | 0.115 | 0.055 | Potassium channel (ATP-sensitive) activator | 0.055 0.022 DBMET01255 | DBMET01255 | |
| 0.031 | 0.118 | 0.058 | Potassium channel (Inward rectifier) activator | 0.058 0.023 DBMET01255 | DBMET01255 | |
| 0.013 | 0.105 | 0.026 | Calcium-sensing receptor agonist | 0.026 0.019 DBMET01255 | DBMET01255 | |
| 0.046 | 0.142 | 0.069 | Exportin-1 inhibitor | 0.069 0.044 DBMET01255 | DBMET01255 | |
| 0.116 | 0.213 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.129 0.123 DBMET00140 0.131 0.115 DBMET00141 | DBMET00141 | |
| 0.102 | 0.204 | 0.425 | Aldehyde oxidase inhibitor | 0.377 0.05 DBMET00138 0.222 0.094 DBMET00139 0.425 0.043 DBMET00140 0.171 0.122 DBMET01255 | DBMET00140 | |
| 0.011 | 0.122 | 0.026 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET00141 | DBMET00141 | |
| 0.135 | 0.25 | 0.374 | Cholesterol antagonist | 0.374 0.056 DBMET00141 | DBMET00141 | |
| 0.064 | 0.182 | 0.198 | Alpha-N-acetylglucosaminidase inhibitor | 0.149 0.055 DBMET00140 0.198 0.035 DBMET00141 | DBMET00141 | |
| 0.123 | 0.241 | 0.186 | Superoxide dismutase inhibitor | 0.165 0.162 DBMET00140 0.186 0.134 DBMET01255 | DBMET01255 | |
| 0.017 | 0.135 | 0.045 | Factor XIa inhibitor | 0.045 0.023 DBMET00140 | DBMET00140 | |
| 0.012 | 0.135 | 0.051 | Factor VIIa inhibitor | 0.051 0.02 DBMET00140 0.038 0.027 DBMET01255 | DBMET00140 | |
| 0.062 | 0.186 | 0.117 | Microtubule formation inhibitor | 0.117 0.064 DBMET01255 | DBMET01255 | |
| 0.033 | 0.164 | 0.075 | Phospholipase D inhibitor | 0.075 0.042 DBMET00140 | DBMET00140 | |
| 0.05 | 0.181 | 0.138 | UDP-glucose 4-epimerase inhibitor | 0.138 0.033 DBMET00141 | DBMET00141 | |
| 0.069 | 0.207 | 0.271 | Interleukin 1 antagonist | 0.269 0.015 DBMET00139 0.271 0.015 DBMET01255 | DBMET01255 | |
| 0.025 | 0.173 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.049 DBMET01255 | DBMET01255 | |
| 0.004 | 0.155 | 0.101 | Growth hormone secretagogue receptor agonist | 0.101 0.007 DBMET01255 | DBMET01255 | |
| 0.03 | 0.188 | 0.053 | Factor III inhibitor | 0.05 0.035 DBMET00138 0.05 0.034 DBMET00140 0.053 0.028 DBMET00141 | DBMET00141 | |
| 0.041 | 0.206 | 0.172 | Expectorant | 0.172 0.027 DBMET00141 | DBMET00141 | |
| 0.019 | 0.188 | 0.071 | Phosphofructokinase-1 inhibitor | 0.071 0.047 DBMET00141 | DBMET00141 | |
| 0.143 | 0.311 | 0.446 | Antibacterial | 0.446 0.058 DBMET00141 | DBMET00141 | |
| 0.007 | 0.18 | 0.055 | Sodium/glucose cotransporter 2 inhibitor | 0.055 0.005 DBMET00141 | DBMET00141 | |
| 0.057 | 0.24 | 0.107 | Cathepsin H inhibitor | 0.107 0.095 DBMET00140 0.104 0.1 DBMET01255 | DBMET00140 | |
| 0.008 | 0.191 | 0.031 | Growth hormone releasing factor agonist | 0.031 0.025 DBMET01255 | DBMET01255 | |
| 0.119 | 0.303 | 0.182 | Neuropeptide Y2 antagonist | 0.182 0.155 DBMET01255 | DBMET01255 | |
| 0.018 | 0.203 | 0.039 | GHS receptor agonist | 0.039 0.035 DBMET01255 | DBMET01255 | |
| 0.029 | 0.215 | 0.1 | Rho-associated kinase II inhibitor | 0.1 0.031 DBMET00140 0.096 0.034 DBMET01255 | DBMET00140 | |
| 0.008 | 0.202 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.039 0.007 DBMET00141 | DBMET00141 | |
| 0.024 | 0.219 | 0.072 | Rho-associated kinase inhibitor | 0.072 0.053 DBMET00140 | DBMET00140 | |
| 0.041 | 0.239 | 0.108 | Cell adhesion molecule inhibitor | 0.08 0.053 DBMET00140 0.108 0.03 DBMET00141 | DBMET00141 | |
| 0.064 | 0.263 | 0.119 | MAP3K9 inhibitor | 0.119 0.116 DBMET00140 | DBMET00140 | |
| 0.114 | 0.315 | 0.55 | Antithrombotic | 0.241 0.133 DBMET00140 0.55 0.022 DBMET00141 | DBMET00141 | |
| 0.046 | 0.254 | 0.089 | Electrolyte absorption antagonist | 0.089 0.075 DBMET01255 | DBMET01255 | |
| 0.003 | 0.217 | 0.042 | Estrogen receptor alpha agonist | 0.042 0.02 DBMET00138 | DBMET00138 | |
| 0.005 | 0.22 | 0.037 | Factor X inhibitor | 0.037 0.028 DBMET00140 | DBMET00140 | |
| 0.043 | 0.264 | 0.097 | NADH dehydrogenase inhibitor | 0.097 0.047 DBMET00141 | DBMET00141 | |
| 0.07 | 0.295 | 0.131 | Interleukin 6 antagonist | 0.131 0.123 DBMET01255 | DBMET01255 | |
| 0.033 | 0.266 | 0.286 | Trypsin inhibitor | 0.142 0.008 DBMET00138 0.154 0.007 DBMET00139 0.286 0.004 DBMET00140 0.094 0.019 DBMET00141 | DBMET00140 | |
| 0.077 | 0.314 | 0.328 | Antioxidant | 0.328 0.053 DBMET00141 | DBMET00141 | |
| 0.014 | 0.254 | 0.104 | CC chemokine 5 receptor antagonist | 0.061 0.025 DBMET00139 0.104 0.007 DBMET01255 | DBMET01255 | |
| 0.181 | 0.423 | 0.269 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.269 0.258 DBMET01255 | DBMET01255 | |
| 0.03 | 0.273 | 0.08 | Potassium channel activator | 0.08 0.075 DBMET01255 | DBMET01255 | |
| 0.004 | 0.247 | 0.029 | Estrogen receptor beta agonist | 0.029 0.024 DBMET00138 | DBMET00138 | |
| 0.004 | 0.261 | 0.047 | GP IIb/IIIa receptor antagonist | 0.047 0.034 DBMET00140 | DBMET00140 | |
| 0.021 | 0.283 | 0.208 | Thrombin inhibitor | 0.129 0.015 DBMET00138 0.138 0.013 DBMET00139 0.208 0.006 DBMET00140 0.115 0.02 DBMET00141 | DBMET00140 | |
| 0.057 | 0.321 | 0.131 | Neuropeptide Y1 antagonist | 0.122 0.119 DBMET00140 0.131 0.098 DBMET01255 | DBMET01255 | |
| 0.031 | 0.298 | 0.105 | Alkylator | 0.105 0.083 DBMET01255 | DBMET01255 | |
| 0.005 | 0.284 | 0.032 | Factor XI inhibitor | 0.032 0.028 DBMET00140 | DBMET00140 | |
| 0.015 | 0.296 | 0.163 | CXC chemokine receptor antagonist | 0.163 0.009 DBMET01255 | DBMET01255 | |
| 0.076 | 0.367 | 0.219 | Transcription factor NF kappa B inhibitor | 0.219 0.151 DBMET00141 | DBMET00141 | |
| 0.05 | 0.343 | 0.252 | Anticonvulsant | 0.252 0.057 DBMET01255 | DBMET01255 | |
| 0.084 | 0.383 | 0.148 | Neurotensin receptor agonist | 0.148 0.106 DBMET00140 | DBMET00140 | |
| 0.013 | 0.318 | 0.057 | Alpha-mannosidase inhibitor | 0.057 0.031 DBMET00141 | DBMET00141 | |
| 0.009 | 0.322 | 0.056 | Mannosidase inhibitor | 0.056 0.02 DBMET00141 | DBMET00141 | |
| 0.055 | 0.37 | 0.131 | Sphingosine 1-phosphate receptor 2 antagonist | 0.131 0.073 DBMET01255 | DBMET01255 | |
| 0.101 | 0.422 | 0.341 | Peptidyltransferase inhibitor | 0.168 0.151 DBMET00140 0.341 0.014 DBMET00141 0.188 0.116 DBMET01255 | DBMET00141 | |
| 0.045 | 0.369 | 0.344 | Immunostimulant | 0.344 0.066 DBMET00141 | DBMET00141 | |
| 0.049 | 0.388 | 0.22 | Interleukin agonist | 0.22 0.102 DBMET00141 | DBMET00141 | |
| 0.036 | 0.381 | 0.296 | Anticoagulant | 0.238 0.041 DBMET00140 0.296 0.029 DBMET00141 | DBMET00141 | |
| 0.011 | 0.378 | 0.049 | Neuraminidase (Influenza A) inhibitor | 0.049 0.026 DBMET00141 | DBMET00141 | |
| 0.026 | 0.397 | 0.138 | Estrogen receptor beta antagonist | 0.138 0.019 DBMET00138 | DBMET00138 | |
| 0.038 | 0.418 | 0.345 | Interleukin antagonist | 0.133 0.132 DBMET00139 0.345 0.039 DBMET01255 | DBMET01255 | |
| 0.032 | 0.413 | 0.223 | Interleukin 1b antagonist | 0.223 0.015 DBMET00139 0.212 0.017 DBMET01255 | DBMET00139 | |
| 0.036 | 0.416 | 0.169 | Cell adhesion inhibitor | 0.169 0.036 DBMET00141 | DBMET00141 | |
| 0.005 | 0.387 | 0.044 | Estrogen agonist | 0.044 0.039 DBMET00138 | DBMET00138 | |
| 0.016 | 0.404 | 0.058 | Heparanase inhibitor | 0.058 0.027 DBMET00141 | DBMET00141 | |
| 0.013 | 0.415 | 0.326 | Analgesic, opioid | 0.326 0.005 DBMET00141 | DBMET00141 | |
| 0.052 | 0.455 | 0.134 | Interferon gamma antagonist | 0.134 0.103 DBMET00141 | DBMET00141 | |
| 0.073 | 0.486 | 0.285 | Vasodilator, coronary | 0.285 0.101 DBMET00141 | DBMET00141 | |
| 0.03 | 0.451 | 0.15 | Estrogen antagonist | 0.15 0.023 DBMET00138 | DBMET00138 | |
| 0.091 | 0.524 | 0.404 | Interleukin 2 agonist | 0.203 0.184 DBMET00138 0.242 0.128 DBMET00140 0.404 0.026 DBMET00141 | DBMET00141 | |
| 0.033 | 0.471 | 0.321 | Free radical scavenger | 0.321 0.046 DBMET00141 | DBMET00141 | |
| 0.046 | 0.489 | 0.165 | NOS3 expression enhancer | 0.165 0.06 DBMET00141 | DBMET00141 | |
| 0.029 | 0.492 | 0.266 | Platelet antagonist | 0.192 0.107 DBMET00140 0.266 0.066 DBMET00141 | DBMET00141 | |
| 0.01 | 0.479 | 0.047 | GHS receptor antagonist | 0.031 0.024 DBMET00140 0.047 0.008 DBMET01255 | DBMET01255 | |
| 0.079 | 0.556 | 0.134 | CC chemokine 6 receptor antagonist | 0.134 0.055 DBMET00141 | DBMET00141 | |
| 0.005 | 0.494 | 0.115 | Opioid agonist | 0.115 0.011 DBMET00141 | DBMET00141 | |
| 0.034 | 0.524 | 0.183 | DNA synthesis inhibitor | 0.183 0.149 DBMET00141 | DBMET00141 | |
| 0.004 | 0.521 | 0.252 | Opioid kappa receptor agonist | 0.252 0.004 DBMET00141 | DBMET00141 | |
| 0.039 | 0.557 | 0.292 | Hepatoprotectant | 0.292 0.032 DBMET00141 | DBMET00141 | |
| 0.017 | 0.539 | 0.111 | Lipid peroxidase inhibitor | 0.111 0.103 DBMET00141 | DBMET00141 | |
| 0.009 | 0.548 | 0.172 | Chemokine receptor antagonist | 0.172 0.024 DBMET01255 | DBMET01255 | |
| 0.038 | 0.581 | 0.304 | Immunosuppressant | 0.304 0.113 DBMET00141 | DBMET00141 | |
| 0.009 | 0.584 | 0.145 | Diuretic | 0.145 0.081 DBMET01255 | DBMET01255 | |
| 0.007 | 0.582 | 0.104 | CC chemokine receptor antagonist | 0.104 0.033 DBMET01255 | DBMET01255 | |
| 0.009 | 0.589 | 0.081 | Nitric oxide donor | 0.081 0.021 DBMET00141 | DBMET00141 | |
| 0.007 | 0.595 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.044 DBMET00141 | DBMET00141 | |
| 0.014 | 0.612 | 0.106 | AMP-activated protein kinase stimulant | 0.106 0.062 DBMET00141 | DBMET00141 | |
| 0.015 | 0.614 | 0.231 | Thrombolytic | 0.231 0.039 DBMET00141 | DBMET00141 | |
| 0.016 | 0.632 | 0.103 | Ca(v)3.2 blocker | 0.103 0.008 DBMET00140 0.066 0.028 DBMET01255 | DBMET00140 | |
| 0.004 | 0.652 | 0.075 | Antineoplastic antibiotic | 0.075 0.061 DBMET00141 | DBMET00141 | |
| 0.035 | 0.767 | 0.3 | Apoptosis antagonist | 0.3 0.085 DBMET00141 | DBMET00141 | |
| 0.023 | 0.773 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.048 DBMET00141 | DBMET00141 | |
| 0.02 | 0.791 | 0.382 | Hypoglycemic | 0.382 0.031 DBMET00141 | DBMET00141 | |
| 0.005 | 0.788 | 0.085 | Topoisomerase I inhibitor | 0.085 0.084 DBMET00141 | DBMET00141 | |
| 0.006 | 0.793 | 0.066 | Protein 50S ribosomal subunit inhibitor | 0.066 0.026 DBMET00141 | DBMET00141 | |
| 0.009 | 0.835 | 0.667 | Angiogenesis stimulant | 0.667 0.005 DBMET00141 | DBMET00141 | |
| 0.008 | 0.837 | 0.048 | Glucose-6-phosphate translocase inhibitor | 0.048 0.043 DBMET00141 | DBMET00141 | |
| 0.007 | 0.842 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 DBMET00141 | DBMET00141 | |
| 0.003 | 0.892 | 0.06 | Secretase gamma inhibitor | 0.039 0.032 DBMET00140 0.06 0.019 DBMET01255 | DBMET01255 | |
| 0.005 | 0.903 | 0.193 | Nitric oxide antagonist | 0.193 0.07 DBMET00141 | DBMET00141 | |
| 0.009 | 0.912 | 0.212 | Platelet adhesion inhibitor | 0.212 0.065 DBMET00141 | DBMET00141 | |
| 0.006 | 0.91 | 0.473 | Analgesic | 0.473 0.057 DBMET00141 | DBMET00141 | |
| 0.005 | 0.96 | 0.266 | Apoptosis agonist | 0.266 0.199 DBMET00141 | DBMET00141 | |
| 0.005 | 0.962 | 0.32 | Cyclophilin D inhibitor | 0.32 0.145 DBMET00141 | DBMET00141 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |